BRWM
INFI

B. Riley Wealth Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

B. Riley Wealth Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-19,000
Closed -$65K – 703
2021
Q3 		$65K Buy
+19,000
New +$58.6K 0.01% 622

Other funds holding INFI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

B. Riley Wealth Management's INFI Position: Q4 2021 in Review

B. Riley Wealth Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2021, closing a stake of 19,000 shares — an estimated $65K sold.

B. Riley Wealth Management first reported a position in INFI in Q3 2021 and held it in 1 quarter. The position peaked at $65K in Q3 2021. 97 funds tracked by Wall St. Rank hold INFI as of Q4 2021.

  • B. Riley Wealth Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
  • B. Riley Wealth Management sold 19,000 Infinity Pharmaceuticals, Inc. shares in Q4 2021, an estimated $65K.
  • B. Riley Wealth Management first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2021 and held it in 1 quarter.
  • B. Riley Wealth Management's Infinity Pharmaceuticals, Inc. position peaked at $65K in Q3 2021.
  • 97 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2021.

Based on B. Riley Wealth Management's 13F filing for Q4 2021, filed 10 Feb 2022.